Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study. Swiss Med Wkly [Internet]. 2023 Mar. 30 [cited 2025 Dec. 11];153(3):40055. Available from: https://www.smw.ch/index.php/smw/article/view/3307